Generic drugmaker Actavis plc (NYSE:ACT), which earlier in November agreed to acquire Botox maker Allergan Inc. for $66 billion, plans to cut its workforce and expand in China, Bloomberg reported Monday, citing Actavis Chief Executive Officer Brent Saunders. Actavis plc (NYSE:ACT) belongs to Healthcare sector. Its net profit margin is -8.10% and weekly performance is 7.64%. On last trading day company shares ended up $266.88. … Continue reading Moving Stocks: Actavis plc (NYSE:ACT), Arch Coal Inc. (NYSE:ACI), B Communications Ltd (NASDAQ:BCOM), Northrim Bancorp Inc. (NASDAQ:NRIM), Neonode, Inc. (NASDAQ:NEON)